Holtzman, S., Danziger, N., Kelly, A., Quintanilha, J., Li, G., Lin, D., … Blank, S. (2025). Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer. In Gynecologic Oncology (Vol. 200, pp. 45–46). Elsevier BV. https://doi.org/10.1016/j.ygyno.2025.04.015

Holtzman, Sharonne, Natalie Danziger, Andrew Kelly, Julia Quintanilha, Gerald Li, Douglas Lin, Ryon Graf, et al. “Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer.” In Gynecologic Oncology, 200:45–46. Elsevier BV, 2025. https://doi.org/10.1016/j.ygyno.2025.04.015.

Holtzman S, Danziger N, Kelly A, Quintanilha J, Li G, Lin D, et al. Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer. In: Gynecologic Oncology. Elsevier BV; 2025. p. 45–6.

Holtzman, Sharonne, et al. “Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer.” Gynecologic Oncology, vol. 200, Elsevier BV, 2025, pp. 45–46. Crossref, doi:10.1016/j.ygyno.2025.04.015.

Holtzman S, Danziger N, Kelly A, Quintanilha J, Li G, Lin D, Graf R, Elvin J, Pothuri B, Secord AA, Blank S. Association of a homologous recombination deficiency signature with oncologic outcomes in advanced endometrial cancer. Gynecologic Oncology. Elsevier BV; 2025. p. 45–46.